skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Discovery and optimization of 1,7-disubstituted-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-ones as potent and selective PKCθ inhibitors

Authors:
; ; ; ; ; ; ; ; ; ; ; ; ;
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1337404
Grant/Contract Number:  
AC02-05CH11231
Resource Type:
Publisher's Accepted Manuscript
Journal Name:
Bioorganic and Medicinal Chemistry
Additional Journal Information:
Journal Name: Bioorganic and Medicinal Chemistry Journal Volume: 24 Journal Issue: 11; Journal ID: ISSN 0968-0896
Publisher:
Elsevier
Country of Publication:
United Kingdom
Language:
English

Citation Formats

Katoh, Taisuke, Takai, Takafumi, Yukawa, Takafumi, Tsukamoto, Tetsuya, Watanabe, Etsurou, Mototani, Hideyuki, Arita, Takeo, Hayashi, Hiroki, Nakagawa, Hideyuki, Klein, Michael G., Zou, Hua, Sang, Bi-Ching, Snell, Gyorgy, and Nakada, Yoshihisa. Discovery and optimization of 1,7-disubstituted-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-ones as potent and selective PKCθ inhibitors. United Kingdom: N. p., 2016. Web. https://doi.org/10.1016/j.bmc.2016.04.008.
Katoh, Taisuke, Takai, Takafumi, Yukawa, Takafumi, Tsukamoto, Tetsuya, Watanabe, Etsurou, Mototani, Hideyuki, Arita, Takeo, Hayashi, Hiroki, Nakagawa, Hideyuki, Klein, Michael G., Zou, Hua, Sang, Bi-Ching, Snell, Gyorgy, & Nakada, Yoshihisa. Discovery and optimization of 1,7-disubstituted-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-ones as potent and selective PKCθ inhibitors. United Kingdom. https://doi.org/10.1016/j.bmc.2016.04.008
Katoh, Taisuke, Takai, Takafumi, Yukawa, Takafumi, Tsukamoto, Tetsuya, Watanabe, Etsurou, Mototani, Hideyuki, Arita, Takeo, Hayashi, Hiroki, Nakagawa, Hideyuki, Klein, Michael G., Zou, Hua, Sang, Bi-Ching, Snell, Gyorgy, and Nakada, Yoshihisa. Wed . "Discovery and optimization of 1,7-disubstituted-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-ones as potent and selective PKCθ inhibitors". United Kingdom. https://doi.org/10.1016/j.bmc.2016.04.008.
@article{osti_1337404,
title = {Discovery and optimization of 1,7-disubstituted-2,2-dimethyl-2,3-dihydroquinazolin-4(1H)-ones as potent and selective PKCθ inhibitors},
author = {Katoh, Taisuke and Takai, Takafumi and Yukawa, Takafumi and Tsukamoto, Tetsuya and Watanabe, Etsurou and Mototani, Hideyuki and Arita, Takeo and Hayashi, Hiroki and Nakagawa, Hideyuki and Klein, Michael G. and Zou, Hua and Sang, Bi-Ching and Snell, Gyorgy and Nakada, Yoshihisa},
abstractNote = {},
doi = {10.1016/j.bmc.2016.04.008},
journal = {Bioorganic and Medicinal Chemistry},
number = 11,
volume = 24,
place = {United Kingdom},
year = {2016},
month = {6}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
https://doi.org/10.1016/j.bmc.2016.04.008

Citation Metrics:
Cited by: 5 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Protein Kinase C θ Affects Ca2+ Mobilization and NFAT Activation in Primary Mouse T Cells
journal, June 2003

  • Pfeifhofer, Christa; Kofler, Kurt; Gruber, Thomas
  • Journal of Experimental Medicine, Vol. 197, Issue 11
  • DOI: 10.1084/jem.20020234

PKC inhibitors: potential in T cell-dependent immune diseases
journal, April 2009


Resistance to Experimental Autoimmune Encephalomyelitis and Impaired IL-17 Production in Protein Kinase Cθ-Deficient Mice
journal, February 2006


Structure–Activity Relationship and Pharmacokinetic Studies of Sotrastaurin (AEB071), a Promising Novel Medicine for Prevention of Graft Rejection and Treatment of Psoriasis
journal, September 2011

  • Wagner, Jürgen; von Matt, Peter; Faller, Bernard
  • Journal of Medicinal Chemistry, Vol. 54, Issue 17
  • DOI: 10.1021/jm200469u

Identification, Characterization and Initial Hit-to-Lead Optimization of a Series of 4-Arylamino-3-Pyridinecarbonitrile as Protein Kinase C theta (PKCθ) Inhibitors
journal, September 2008

  • Cole, Derek C.; Asselin, Magda; Brennan, Agnes
  • Journal of Medicinal Chemistry, Vol. 51, Issue 19
  • DOI: 10.1021/jm800214a

Differential Regulation of Th2 and Th1 Lung Inflammatory Responses by Protein Kinase Cθ
journal, November 2004


Discovery of Selective and Orally Bioavailable Protein Kinase Cθ (PKCθ) Inhibitors from a Fragment Hit
journal, July 2014

  • George, Dawn M.; Breinlinger, Eric C.; Friedman, Michael
  • Journal of Medicinal Chemistry, Vol. 58, Issue 1
  • DOI: 10.1021/jm500669m

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Second generation 4-(4-methyl-1H-indol-5-ylamino)-2-phenylthieno[2,3-b]pyridine-5-carbonitrile PKCθ inhibitors
journal, February 2009

  • Wu, Biqi; Boschelli, Diane H.; Lee, Julie
  • Bioorganic & Medicinal Chemistry Letters, Vol. 19, Issue 3
  • DOI: 10.1016/j.bmcl.2008.12.021

Optimization of 2,4-diamino-5-fluoropyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug–drug interactions and P-gp liability
journal, July 2015

  • Kunikawa, Shigeki; Tanaka, Akira; Mukoyoshi, Koichiro
  • Bioorganic & Medicinal Chemistry, Vol. 23, Issue 13
  • DOI: 10.1016/j.bmc.2015.04.050

Protein kinase Cθ: a new essential superstar on the T-cell stage
journal, November 2000


Structure-based optimization of aminopyridines as PKCθ inhibitors
journal, July 2012

  • Jimenez, Juan-Miguel; Davis, Christopher; Boyall, Dean
  • Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 14
  • DOI: 10.1016/j.bmcl.2012.05.114

Effect of AS2521780, a novel PKCθ selective inhibitor, on T cell-mediated immunity
journal, December 2014


Design and Optimization of Selective Protein Kinase C θ (PKCθ) Inhibitors for the Treatment of Autoimmune Diseases
journal, February 2013

  • Jimenez, Juan-Miguel; Boyall, Dean; Brenchley, Guy
  • Journal of Medicinal Chemistry, Vol. 56, Issue 5
  • DOI: 10.1021/jm301465a

Effect of novel PKCθ selective inhibitor AS2521780 on acute rejection in rat and non-human primate models of transplantation
journal, August 2015


Catalytic Domain Crystal Structure of Protein Kinase C-θ (PKCθ)
journal, September 2004

  • Xu, Zhang-Bao; Chaudhary, Divya; Olland, Stephane
  • Journal of Biological Chemistry, Vol. 279, Issue 48
  • DOI: 10.1074/jbc.M409216200

Aurora Kinase Inhibitors Based on the Imidazo[1,2- a ]pyrazine Core: Fluorine and Deuterium Incorporation Improve Oral Absorption and Exposure
journal, January 2011

  • Kerekes, Angela D.; Esposite, Sara J.; Doll, Ronald J.
  • Journal of Medicinal Chemistry, Vol. 54, Issue 1
  • DOI: 10.1021/jm1010995

PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes
journal, March 2000

  • Sun, Zuoming; Arendt, Christopher W.; Ellmeier, Wilfried
  • Nature, Vol. 404, Issue 6776
  • DOI: 10.1038/35006090

C-5 substituted heteroaryl-3-pyridinecarbonitriles as PKCθ inhibitors: Part II
journal, October 2009

  • Prashad, Amar S.; Wang, Daniel; Subrath, Joan
  • Bioorganic & Medicinal Chemistry Letters, Vol. 19, Issue 19
  • DOI: 10.1016/j.bmcl.2009.07.113

Benzylic Oxidation of Gemfibrozil-1- O -β-Glucuronide by P450 2C8 Leads to Heme Alkylation and Irreversible Inhibition
journal, May 2009

  • Baer, Brian R.; DeLisle, Robert Kirk; Allen, Andrew
  • Chemical Research in Toxicology, Vol. 22, Issue 7
  • DOI: 10.1021/tx900105n

Kinome Render: a stand-alone and web-accessible tool to annotate the human protein kinome tree
journal, January 2013

  • Chartier, Matthieu; Chénard, Thierry; Barker, Jonathan
  • PeerJ, Vol. 1
  • DOI: 10.7717/peerj.126

The CCP4 suite programs for protein crystallography
journal, September 1994


Optimized Protein Kinase Cθ (PKCθ) Inhibitors Reveal Only Modest Anti-inflammatory Efficacy in a Rodent Model of Arthritis
journal, July 2014

  • George, Dawn M.; Breinlinger, Eric C.; Argiriadi, Maria A.
  • Journal of Medicinal Chemistry, Vol. 58, Issue 1
  • DOI: 10.1021/jm5013006

Discovery of potent and selective PKC-θ inhibitors
journal, January 2007

  • Cywin, Charles L.; Dahmann, Georg; Prokopowicz, Anthony S.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 17, Issue 1
  • DOI: 10.1016/j.bmcl.2006.09.056

PKC and the control of localized signal dynamics
journal, February 2010

  • Rosse, Carine; Linch, Mark; Kermorgant, Stéphanie
  • Nature Reviews Molecular Cell Biology, Vol. 11, Issue 2
  • DOI: 10.1038/nrm2847

Conformational restriction: an effective tactic in 'follow-on'-based drug discovery
journal, May 2014

  • Fang, Zengjun; Song, Yu’ning; Zhan, Peng
  • Future Medicinal Chemistry, Vol. 6, Issue 8
  • DOI: 10.4155/fmc.14.50

[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997


Metabolic Soft Spot Identification and Compound Optimization in Early Discovery Phases Using MetaSite and LC-MS/MS Validation
journal, January 2009

  • Trunzer, Markus; Faller, Bernard; Zimmerlin, Alfred
  • Journal of Medicinal Chemistry, Vol. 52, Issue 2
  • DOI: 10.1021/jm8008663

Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206

Discovery of 3-(1 H -Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C Isotypes
journal, October 2009

  • Wagner, Jürgen; von Matt, Peter; Sedrani, Richard
  • Journal of Medicinal Chemistry, Vol. 52, Issue 20
  • DOI: 10.1021/jm901108b